19.11.2022 - VANCOUVER, BC / ACCESSWIRE / November 18, 2022 / Core One Labs Inc. (CSE:COOL), (OTCQB:CLABF), (Frankfurt:LD6, WKN:A3CSSU) (the Company or Core One ) is pleased to announce the initial production run of its psilocybin active pharmaceutical . Seite 1